Last updated on RxList: 6/22/2020
Dexycu Side Effects Center

What Is Dexycu?

Dexycu (dexamethasone intraocular suspension) 9% is a corticosteroid indicated for the treatment of postoperative inflammation.

What Are Side Effects of Dexycu?

Common side effects of Dexycu include:

  • increased fluid pressure inside the eye,
  • corneal swelling,
  • inflammation of the iris (iritis),
  • puffy eyelids,
  • eye pain or inflammation,
  • blurred vision,
  • reduced visual sharpness,
  • eye "floaters,"
  • feeling as if something is in the eye, and
  • sensitivity to light

Dosage for Dexycu

The dose of Dexycu is 0.005 mL administered into the posterior chamber inferiorly behind the iris at the end of ocular surgery.

What Drugs, Substances, or Supplements Interact with Dexycu?

Dexycu may interact with other drugs. Tell your doctor all medications and supplements you use.

Dexycu During Pregnancy and Breastfeeding

Tell your doctor if you are pregnant or plan to become pregnant before using Dexycu; it is unknown how it would affect a fetus. It is unknown if topical eye administration of Dexycu passes into breast milk. Systemically administered corticosteroids pass into breast milk and may cause adverse effects in nursing infants. Consult your doctor before breastfeeding.

Additional Information

Our Dexycu (dexamethasone intraocular suspension) 9%, for Intraocular Administration Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What causes dry eyes? See Answer
Dexycu Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • eye pain or redness;
  • blurred vision, tunnel vision, or seeing halos around lights;
  • cloudy or hazy vision;
  • eyebrow pain;
  • changes in the shape of your pupil;
  • increased sensitivity of your eyes to light; or
  • signs of eye infection--swelling, redness, severe discomfort, crusting or drainage.

Repeat treatments with Ozurdex may cause you to develop cataracts, which can affect your vision and may require surgical treatment. Your doctor will determine how often to treat you with this medicine.

Common side effects may include:

  • vision problems;
  • seeing "floaters" in your vision;
  • eye pain or redness;
  • feeling like something is in your eye;
  • eyelid swelling;
  • dry eyes;
  • headache; or
  • your eyes may be more sensitive to light.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Dexycu (Dexamethasone Intraocular Suspension 9%, for Intraocular Administration)


Pink Eye (Conjunctivitis) Symptoms, Causes, Treatments See Slideshow
Dexycu Professional Information


The following adverse reactions are described elsewhere in the labeling:

  • Increase in Intraocular Pressure [see WARNINGS AND PRECAUTIONS]
  • Delayed Healing [see WARNINGS AND PRECAUTIONS]
  • Infection Exacerbation [see WARNINGS AND PRECAUTIONS]
  • Cataract Progression [see WARNINGS AND PRECAUTIONS]

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

The following adverse events rates are derived from three clinical trials in which 339 patients received the 517 microgram dose of DEXYCU. The most commonly reported adverse reactions occurred in 5-15% of subjects and included increases in intraocular pressure, corneal edema and iritis. Other ocular adverse reactions occurring in 1-5% of subjects included, corneal endothelial cell loss, blepharitis, eye pain, cystoid macular edema, dry eye, ocular inflammation, posterior capsule opacification, blurred vision, reduced visual acuity, vitreous floaters, foreign body sensation, photophobia, and vitreous detachment.

Read the entire FDA prescribing information for Dexycu (Dexamethasone Intraocular Suspension 9%, for Intraocular Administration)

© Dexycu Patient Information is supplied by Cerner Multum, Inc. and Dexycu Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors